FDA lost a second legal battle over its orphan drug exclusivity policy. However, the outcome will not benefit other drugs in similar situations since legislation was enacted last year mandating a "clinical superiority test" for an orphan drug that is the "same" as a previously approved drug.
The US District Court for the District of Columbia ordered FDA to award Eagle Pharmaceuticals Inc.'s Bendeka (bendamustine) seven...





